Your Cancer is Gone; Type 1 Diabetes is Here
Immune therapy has transformed cancer care. In some cases, cancer is effectively cured in people with stage 4 disease. But…
Advancing the Cure with Type 1 Diabetes Clinical Trials
Breakthrough T1D funds type 1 diabetes (T1D) clinical trials that are critical to bringing new devices and treatments to people…
Pump Choice Should Be in the Hands of Those with T1D, NOT Health Insurance Plans
As many of you know, UnitedHealthcare (UHC) has limited insulin pump choice for children and adults through a new policy…
JDRF’s Nicole Johnson Stresses the Need for Mental and Emotional Balance with T1D
When you have type 1 diabetes (T1D), people might see the CGM on your arm, the pump tubing, or the…
Closer to Cure: Renewed Funding for Type 1 Diabetes UK Immunotherapy Consortium (T1D UK)
More than 400,000 people in the United Kingdom and 1.25 million Americans have type 1 diabetes (T1D), a disease for…
Want to Stave Off Type 1 Diabetes? Beta Cell Proliferation May Be the Key
In Nature Metabolism, Breakthrough T1D-funded researchers—including the lead author, Ercument Dirice, Ph.D., and senior author, Rohit Kulkarni, M.D., Ph.D.—found an…
A DIY approach to artificial pancreas technology
Discover how the DIY approach to artificial pancreas technology is empowering people with type 1 diabetes.
Breakthrough T1D Expresses Profound Loss at the Passing of Helaine Shiff, co-founder of Breakthrough T1D Canada
Breakthrough T1D International is deeply saddened at the loss of one of Breakthrough T1D Canada’s co-founders, Helaine Shiff. “Helaine was…
A Win for the European T1D Community: Zynquista (sotagliflozin) Approved for Type 1 Diabetes
In a second win for the type 1 diabetes (T1D) community, the European Commission has approved Zynquista™ (sotagliflozin) for use…
End-stage kidney disease: A possible biomarker of 10-year risk—and therapeutic target—for people with T1D
In the United States, diabetic kidney disease, or DKD, is responsible for more than half of all new cases of…
